Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. [electronic resource]
Producer: 20110525Description: 530-7 p. digitalISSN:- 1523-4681
- Acid Phosphatase -- blood
- Aged
- Aged, 80 and over
- Alkaline Phosphatase -- blood
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone Density Conservation Agents -- pharmacology
- Bone Remodeling -- drug effects
- Collagen Type I -- blood
- Denosumab
- Dose-Response Relationship, Drug
- Female
- Humans
- Isoenzymes -- blood
- Middle Aged
- Osteoporosis, Postmenopausal -- blood
- Peptide Fragments -- blood
- Peptides -- blood
- Procollagen -- blood
- RANK Ligand -- pharmacology
- Reference Values
- Statistics, Nonparametric
- Tartrate-Resistant Acid Phosphatase
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.